Carl Zeiss Meditec AG
Company Profile
Business description
Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
Contact
Goschwitzer Strasse 51-52
JenaTH07745
DEUT: +49 3641220115
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2025
Employees
5,730
Stocks News & Analysis
stocks
WiseTech result disappoints, but the future looks bright
stocks
WOW earnings: Woolworths losing market share, but will catch up to Coles
stocks
Chart of the Week: Largest share price falls during earnings
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,241.10 | 0.50 | -0.01% |
CAC 40 | 7,780.84 | 36.91 | 0.48% |
DAX 40 | 24,077.50 | 31.29 | 0.13% |
Dow JONES (US) | 45,565.23 | 147.16 | 0.32% |
FTSE 100 | 9,218.93 | 36.57 | -0.40% |
HKSE | 24,998.82 | 202.94 | -0.81% |
NASDAQ | 21,590.14 | 45.87 | 0.21% |
Nikkei 225 | 42,828.79 | 308.52 | 0.73% |
NZX 50 Index | 12,903.08 | 41.24 | 0.32% |
S&P 500 | 6,481.40 | 15.46 | 0.24% |
S&P/ASX 200 | 8,980.00 | 9.50 | 0.11% |
SSE Composite Index | 3,843.60 | 43.25 | 1.14% |